Hydroxychloroquine (HCQ), one of the most commonly used immunosuppressants for the treatment of RA, has a protective effect against RA arthritis by inhibiting DC maturation and migration through blocking TLR9 (178). Here, TLR9 is linked to arthritic joint disease.